Radiotherapy for oligometastatic cancer: a survey among radiation oncologists of Lombardy (AIRO-Lombardy), Italy

Published on Apr 1, 2019in Radiologia Medica2
· DOI :10.1007/S11547-018-0972-6
Barbara Alicja Jereczek-Fossa36
Estimated H-index: 36
(IEO: European Institute of Oncology),
Bortolato B1
Estimated H-index: 1
+ 30 AuthorsPaolo Antognoni14
Estimated H-index: 14
(Ospedale di Circolo e Fondazione Macchi)
Aims To evaluate the use of radiotherapy (RT) for oligometastatic cancer (OMC) among radiation oncologists in Lombardy, Italy.
📖 Papers frequently viewed together
1 Citations
6 Citations
#1Mauro PalazziH-Index: 1
#1Mauro PalazziH-Index: 11
Last. Roberto OrecchiaH-Index: 71
view all 35 authors...
Introduction:Several efforts are being implemented at the European level to measure provision of up-to-date radiation treatments across the continent.Methods:A snapshot survey involving all radiation oncology centers within Lombardy, Italy, was performed in 2012 and repeated in 2014 and 2016, in cooperation with regional governmental officers. Centers were asked to provide detailed information concerning all individual patients being treated on the index day, and to report data on available loca...
7 CitationsSource
#1Silke Gillessen (University of Bern)H-Index: 58
#2Gerhardt AttardH-Index: 75
Last. Aurelius Omlin (HSG: University of St. Gallen)H-Index: 34
view all 61 authors...
Abstract Background In advanced prostate cancer (APC), successful drug development as well as advances in imaging and molecular characterisation have resulted in multiple areas where there is lack of evidence or low level of evidence. The Advanced Prostate Cancer Consensus Conference (APCCC) 2017 addressed some of these topics. Objective To present the report of APCCC 2017. Design, setting, and participants Ten important areas of controversy in APC management were identified: high-risk localised...
363 CitationsSource
#1Puneeth Iyengar (UTSW: University of Texas Southwestern Medical Center)H-Index: 30
#2Zabi Wardak (UTSW: University of Texas Southwestern Medical Center)H-Index: 10
Last. Robert TimmermanH-Index: 69
view all 13 authors...
Importance Patterns-of-failure studies suggest that in metastatic non–small-cell lung cancer (NSCLC) sites of gross disease at presentation are the first to progress when treated with chemotherapy. This knowledge has led to increased adoption of local ablative radiation therapy in patients with stage IV NSCLC, though prospective randomized evidence is limited. Objective To determine if intervening with noninvasive stereotactic ablative radiotherapy (SAbR) prior to maintenance chemotherapy in pat...
348 CitationsSource
#1Aurélie De Bruycker (UGent: Ghent University)H-Index: 6
#2Bieke Lambert (UGent: Ghent University)H-Index: 26
Last. Piet Ost (UGent: Ghent University)H-Index: 41
view all 18 authors...
Objectives To describe the anatomical patterns of PCa recurrence following primary therapy and investigate if patients with low-volume disease have a better prognosis as compared to their counterparts. Material and methods Patients eligible for a F18-choline PET-CT were entered in a prospective cohort study. Eligible patients had an asymptomatic biochemical recurrence following primary PCa treatment and testosterone levels >50 ng/ml. The number of lesions were counted per scan. Patients with an ...
36 CitationsSource
#1Elise De Bleser (Johns Hopkins University)H-Index: 6
#1Elise De Bleser (Johns Hopkins University)H-Index: 1
Last. Piet Ost (UGent: Ghent University)H-Index: 41
view all 3 authors...
Purpose of reviewTo summarize the available literature regarding radiotherapy as a metastasis-directed therapy (MDT) in the treatment of oligometastatic prostate cancer (PCa).Recent findingsThree different clinical scenarios of oligometastatic PCa exist in which MDT can be applied: de novo oligometa
25 CitationsSource
#1Ciro FranzeseH-Index: 18
#2Antonella FogliataH-Index: 55
Last. Marta ScorsettiH-Index: 45
view all 14 authors...
Objective:The colorectal cancer (CRC) might present loco-regional recurrence, including lymph-node metastasis. Stereotactic body radiotherapy (SBRT) is a non-invasive and well-tolerated ablative treatment. Aim of the present study is to evaluate efficacy and toxicity of SBRT with volumetric modulated arc therapy (VMAT) in this setting.Methods:35 patients presenting a total of 47 nodal recurrences from CRC, treated with VMAT-SBRT from 2008 to 2015, were selected. About three fourth of the treatme...
5 CitationsSource
#1Margriet Kwint (NKI-AVL: Netherlands Cancer Institute)H-Index: 8
#2Iris Walraven (NKI-AVL: Netherlands Cancer Institute)H-Index: 11
Last. José Belderbos (NKI-AVL: Netherlands Cancer Institute)H-Index: 56
view all 8 authors...
Abstract Objectives Patients with stage IV non-small cell lung cancer (NSCLC) are considered incurable and are mainly treated with palliative intent. This patient group has a poor overall survival (OS) and progression free survival (PFS). The purpose of this study was to investigate PFS and OS of NSCLC patients diagnosed with synchronous oligometastatic disease who underwent radical treatment of both intrathoracic disease and metastases. Materials and methods Patients with NSCLC and oligometasta...
20 CitationsSource
#1Filippo Alongi (University of Brescia)H-Index: 33
#1Filippo Alongi (University of Brescia)H-Index: 15
Last. Stefano Maria MagriniH-Index: 25
view all 9 authors...
Abstract Renal Cell Carcinoma (RCC) has historically been considered a radioresistant cancer, and radiotherapy was usually delivered with a palliative goal. Stereotactic ablative radiotherapy (SABR) allows the delivery of high doses on small treatment volumes in a safe and effective way, thus opening the doors to new applicationsof radiotherapy both in the treatment of the primary and oligometastasic disease. Aim of the current review is to explore the state of art of SABR in the therapeutic app...
8 CitationsSource
#1Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 36
#2Giuseppe Fanetti (IEO: European Institute of Oncology)H-Index: 9
Last. Roberto Orecchia (IEO: European Institute of Oncology)H-Index: 71
view all 24 authors...
Abstract Background The purpose of the study was to evaluate the prostate serum antigen (PSA) response, local control, progression-free survival (PFS), and toxicity of stereotactic body radiotherapy (SBRT) for lymph node (LN) oligorecurrent prostate cancer. Patients and Methods Between May 2012 and October 2015, 124 lesions were treated in 94 patients with a median dose of 24 Gy in 3 fractions. Seventy patients were treated for a single lesion and 25 for > 1 lesion. In 34 patients androgen depri...
39 CitationsSource
#1Noura Radwan (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 5
#2Ryan Phillips (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 7
Last. Phuoc T. Tran (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 50
view all 20 authors...
Background We describe a randomized, non-blinded Phase II interventional study to assess the safety and efficacy of stereotactic ablative radiotherapy (SABR) for hormone-sensitive oligometastatic prostate adenocarcinoma, and to describe the biology of the oligometastatic state using immunologic, cellular, molecular, and functional imaging correlates. 54 men with oligometastatic prostate adenocarcinoma will be accrued. The primary clinical endpoint will be progression at 6 months from randomizati...
54 CitationsSource
Cited By6
#1Hiroshi Hongo (Keio: Keio University)H-Index: 8
#2Takeo Kosaka (Keio: Keio University)H-Index: 30
Last. Mototsugu Oya (Keio: Keio University)H-Index: 56
view all 4 authors...
It is still unclear whether cell-free DNA (cfDNA) can replace solid-tissue biopsy. A 59-year-old man developed castration-resistant prostate cancer with a liver metastasis. We performed a liver biopsy and collected a cfDNA sample. Although he underwent radiofrequency ablation, tumors recurred and he was transferred to another hospital. We performed next-generation sequencing using DNA from the biopsy tissue and cfDNA. BRCA2 p.T3033fs and AURKA F31I were detected in both the biopsy tissue and the...
1 CitationsSource
#1Rosario MazzolaH-Index: 19
#2Francesco CucciaH-Index: 7
Last. Filippo AlongiH-Index: 33
view all 16 authors...
OBJECTIVES To report preliminary data on feasibility and patient-reported outcomes following PSMA-PET/CT guided SBRT by means of 1.5 T MRI-Linac. METHODS AND MATERIALS Between October 2019 and April 2020, twenty consecutive castration sensitive oligorecurrent prostate cancer patients were enrolled in an ethical committee approved prospective observational study (Protocol n. XXXX) and treated with PSMA-PET/CT guided SBRT by means of 1.5 T MRI-Linac (Unity, Elekta AB, Stockholm, Sweden). The mean ...
2 CitationsSource
#1Rosario MazzolaH-Index: 19
#2Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 36
Last. Filippo Alongi (University of Brescia)H-Index: 33
view all 14 authors...
In the last years, several evidences demonstrated the role of stereotactic body radiotherapy (SBRT) in the oligometastatic disease and the possibility to increase survival in selected patients. In 2020 the study group "biology and treatment of the oligometastatic disease" of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) conducted a survey evaluating the attitude of physicians in treating the oligometastatic disease and the definition of it. An electronic questionnaire was ...
#1Michela BuglioneH-Index: 21
#2Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 36
Last. Paolo Antognoni (Ospedale di Circolo e Fondazione Macchi)H-Index: 14
view all 21 authors...
Abstract Objectives stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) are a therapeutic option for Oligometastatic/Oligoprogressive (OM/OP) NSCLC. This retrospective multicentre analysis aims to analyse clinical outcomes and treatment related toxicity of patients treated to all sites of know disease with SRS and/or FSRT for OM/OP NSCLC in 8 Italian radiation oncology centres. Materials and methods From January 2016 to January 2017 198 OM/OP NSCLC patients (pts) we...
4 CitationsSource
#1Sergio FersinoH-Index: 14
#2Stefano ArcangeliH-Index: 24
Last. Filippo Alongi (University of Brescia)H-Index: 33
view all 10 authors...
Aims To investigate the role of Radiation Oncology in the management of genito-urinary (GU) cancer excluding prostate and penile cancer.
4 CitationsSource